OPGN Research and Charts

OPGN - OpGen Inc (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-02)

Last 0.53	Change ⇓ -0.07 (0.00%)	Volume 3,760
	Open 0.59	High 0.59	Low 0.53

8EMA (Daily) 0.67	40EMA (Daily) 1.19	50EMA (Daily) 1.29	STO (Daily) 4.945	MACD Hist (Daily) -0.046
8EMA (Weekly) 1.040	40EMA (Weekly) 1.51	50EMA (Weekly) 1.47	STO (Weekly) 3.019	MACD Hist (Weekly) -0.332


Company Profile
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.